ePrints

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

Lookup NU author(s): Professor Chris LambORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel J-F, Hertervig E, GETAID and the SPARE-Biocycle research group

Publication type: Article

Publication status: Published

Journal: The Lancet Gastroenterology and Hepatology

Year: 2023

Volume: 8

Issue: 3

Pages: 215-227

Print publication date: 01/03/2023

Online publication date: 11/01/2023

Acceptance date: 04/11/2022

Date deposited: 23/02/2023

ISSN (print): 2468-1253

ISSN (electronic): 2468-1156

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/S2468-1253(22)00385-5

DOI: 10.1016/S2468-1253(22)00385-5

PubMed id: 36640794

Altmetrics

Funding

Share